CC-Ery Overview

  • Founded
  • 2008
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

CC-Ery General Information


Developer of an artificial oxygen carrier intended to provide blood substitute and oxygen therapeutic for human use. The company's carrier offers an artificial blood substitute to overcome blood donations and other transfusion-related risks enabling doctors to compensate for blood loss during surgery, save lives of victims or to treat patients with anemia and other illnesses.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Medical Supplies
Primary Office
  • Robert-Rössle-Straße 10
  • Gebäude 7
  • 13125 Berlin
  • Germany
+49 030 000000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CC-Ery Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Apr-2018 Completed Out of Business
2. Early Stage VC Completed Startup
1. Accelerator/Incubator Completed Startup
To view CC-Ery’s complete valuation and funding history, request access »

CC-Ery Executive Team (3)

Name Title Board Seat Contact Info
Hans Bäumler Ph.D Co-Founder & Managing Director
Sven-Peter Heyn Managing Director
Andreas Voigt Co-Founder
To view CC-Ery’s complete executive team members history, request access »